Search

Gustavo A. Rosario Benitez

Examiner (ID: 599, Phone: (571)270-7888 , Office: P/2838 )

Most Active Art Unit
2838
Art Unit(s)
2838
Total Applications
811
Issued Applications
625
Pending Applications
91
Abandoned Applications
129

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5236513 [patent_doc_number] => 20070128670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof' [patent_app_type] => utility [patent_app_number] => 10/584728 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12824 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128670.pdf [firstpage_image] =>[orig_patent_app_number] => 10584728 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584728
Methods for the identification and preparation of regulator/suppressor t lymphocytes, compositions and use thereof Dec 22, 2004 Abandoned
Array ( [id] => 7045147 [patent_doc_number] => 20050249742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Compositions and methods for modulating a cytotoxic T lymphocyte immune response' [patent_app_type] => utility [patent_app_number] => 11/022562 [patent_app_country] => US [patent_app_date] => 2004-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14481 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249742.pdf [firstpage_image] =>[orig_patent_app_number] => 11022562 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/022562
Compositions and methods for modulating a cytotoxic T lymphocyte immune response Dec 21, 2004 Abandoned
Array ( [id] => 7193054 [patent_doc_number] => 20050163778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Extracorporeal photopheresis in combination with anti-TNF treatment' [patent_app_type] => utility [patent_app_number] => 11/018240 [patent_app_country] => US [patent_app_date] => 2004-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13140 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163778.pdf [firstpage_image] =>[orig_patent_app_number] => 11018240 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/018240
Extracorporeal photopheresis in combination with anti-TNF treatment Dec 20, 2004 Abandoned
Array ( [id] => 72174 [patent_doc_number] => 07754853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'TNF alpha-binding polypeptide compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/005726 [patent_app_country] => US [patent_app_date] => 2004-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 29 [patent_no_of_words] => 16037 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754853.pdf [firstpage_image] =>[orig_patent_app_number] => 11005726 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/005726
TNF alpha-binding polypeptide compositions and methods Dec 6, 2004 Issued
Array ( [id] => 4523899 [patent_doc_number] => 07951783 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-31 [patent_title] => 'Therapeutically useful molecules' [patent_app_type] => utility [patent_app_number] => 10/581773 [patent_app_country] => US [patent_app_date] => 2004-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6266 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/951/07951783.pdf [firstpage_image] =>[orig_patent_app_number] => 10581773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581773
Therapeutically useful molecules Dec 5, 2004 Issued
Array ( [id] => 5769494 [patent_doc_number] => 20050266004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Anti-human lymphotoxin alpha antibodies, compositions, methods and uses' [patent_app_type] => utility [patent_app_number] => 10/999866 [patent_app_country] => US [patent_app_date] => 2004-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34612 [patent_no_of_claims] => 101 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20050266004.pdf [firstpage_image] =>[orig_patent_app_number] => 10999866 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/999866
Anti-human lymphotoxin alpha antibodies, compositions, methods and uses Nov 29, 2004 Abandoned
Array ( [id] => 6996226 [patent_doc_number] => 20050136004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Anti-IL-20 antibodies and binding partners and methods of using in inflammation' [patent_app_type] => utility [patent_app_number] => 10/994116 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70921 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20050136004.pdf [firstpage_image] =>[orig_patent_app_number] => 10994116 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994116
Immunoconjugates of anti-IL-20 antibodies and hybridoma cell lines expressing anti-IL-20 antibodies Nov 18, 2004 Issued
Array ( [id] => 4484514 [patent_doc_number] => 07883703 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Methods of modulating immunity' [patent_app_type] => utility [patent_app_number] => 10/987380 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 19170 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/883/07883703.pdf [firstpage_image] =>[orig_patent_app_number] => 10987380 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/987380
Methods of modulating immunity Nov 11, 2004 Issued
Array ( [id] => 5828158 [patent_doc_number] => 20060063235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'DNA encoding the human serine protease C-E' [patent_app_type] => utility [patent_app_number] => 10/988164 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17104 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063235.pdf [firstpage_image] =>[orig_patent_app_number] => 10988164 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/988164
DNA encoding the human serine protease C-E Nov 11, 2004 Abandoned
Array ( [id] => 5894396 [patent_doc_number] => 20060002935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/985847 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 62908 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002935.pdf [firstpage_image] =>[orig_patent_app_number] => 10985847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/985847
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor Nov 9, 2004 Abandoned
Array ( [id] => 7159617 [patent_doc_number] => 20050084493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof' [patent_app_type] => utility [patent_app_number] => 10/985299 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20753 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084493.pdf [firstpage_image] =>[orig_patent_app_number] => 10985299 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/985299
Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof Nov 8, 2004 Abandoned
Array ( [id] => 6906375 [patent_doc_number] => 20050101770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => 'Interleukin-10 antibodies' [patent_app_type] => utility [patent_app_number] => 10/985584 [patent_app_country] => US [patent_app_date] => 2004-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21773 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20050101770.pdf [firstpage_image] =>[orig_patent_app_number] => 10985584 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/985584
Interleukin-10 antibodies Nov 8, 2004 Abandoned
Array ( [id] => 6939131 [patent_doc_number] => 20050112694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Antibodies that bind interleukin-4 receptor' [patent_app_type] => utility [patent_app_number] => 10/982359 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 40392 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20050112694.pdf [firstpage_image] =>[orig_patent_app_number] => 10982359 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/982359
Antibodies that bind interleukin-4 receptor Nov 3, 2004 Abandoned
Array ( [id] => 5084945 [patent_doc_number] => 20070274996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Antibodies That Bind Interleukin-4 Receptor' [patent_app_type] => utility [patent_app_number] => 10/578410 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 40389 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274996.pdf [firstpage_image] =>[orig_patent_app_number] => 10578410 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578410
Antibodies that bind interleukin-4 receptor Nov 3, 2004 Issued
Array ( [id] => 7176147 [patent_doc_number] => 20050123542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Methods for treating disorders involving monocytes' [patent_app_type] => utility [patent_app_number] => 10/982725 [patent_app_country] => US [patent_app_date] => 2004-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7325 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20050123542.pdf [firstpage_image] =>[orig_patent_app_number] => 10982725 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/982725
Methods for treating disorders involving monocytes Nov 3, 2004 Abandoned
Array ( [id] => 7182847 [patent_doc_number] => 20050191309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Induction of antigen specific immunologic tolerance' [patent_app_type] => utility [patent_app_number] => 10/980648 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21635 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191309.pdf [firstpage_image] =>[orig_patent_app_number] => 10980648 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/980648
Induction of antigen specific immunologic tolerance Nov 2, 2004 Abandoned
Array ( [id] => 5100774 [patent_doc_number] => 20070184036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Isolated cd4+ t cells defined by cmrf-35' [patent_app_type] => utility [patent_app_number] => 10/577627 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27429 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184036.pdf [firstpage_image] =>[orig_patent_app_number] => 10577627 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577627
Isolated cd4+ t cells defined by cmrf-35 Oct 27, 2004 Abandoned
Array ( [id] => 7127331 [patent_doc_number] => 20050059075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-17 [patent_title] => 'Isolated human zinc metalloprotease, nucleic acid molecules encoding said enzymes, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/971008 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 20224 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20050059075.pdf [firstpage_image] =>[orig_patent_app_number] => 10971008 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/971008
Isolated human zinc metalloprotease, nucleic acid molecules encoding said enzymes, and uses thereof Oct 24, 2004 Abandoned
Array ( [id] => 6912270 [patent_doc_number] => 20050176028 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Deimmunized binding molecules to CD3' [patent_app_type] => utility [patent_app_number] => 10/966406 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 9783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176028.pdf [firstpage_image] =>[orig_patent_app_number] => 10966406 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/966406
Deimmunized binding molecules to CD3 Oct 14, 2004 Abandoned
Array ( [id] => 7005691 [patent_doc_number] => 20050171004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Use of cardiotrophin-1 to promote wound healing and counteract overt fibrosis' [patent_app_type] => utility [patent_app_number] => 10/954159 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 10650 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171004.pdf [firstpage_image] =>[orig_patent_app_number] => 10954159 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/954159
Use of cardiotrophin-1 to promote wound healing and counteract overt fibrosis Sep 29, 2004 Abandoned
Menu